| MeSH term | MeSH ID | Detail |
|---|---|---|
| Hypertension | D006973 | 115 associated lipids |
| Insulin Resistance | D007333 | 99 associated lipids |
Total
2
Tauroursodeoxycholic acid
Tauroursodeoxycholic acid is a lipid of Sterol Lipids (ST) class. Tauroursodeoxycholic acid is associated with abnormalities such as Hyperglycemia, Obesity, Wiskott-Aldrich Syndrome, neurogenic hypertension and Cholestatic liver disease. The involved functions are known as Cell Death, Apoptosis, Homeostasis, Process and mRNA Expression. Tauroursodeoxycholic acid often locates in Body tissue, Endoplasmic Reticulum, Hepatic, Blood and Protoplasm. The associated genes with Tauroursodeoxycholic acid are Homologous Gene and Mutant Proteins. The related lipids are cholanic acid, taurolithocholic acid 3-sulfate, Sterols, 7-dehydrocholesterol and tauromuricholic acid. The related experimental models are Disease model.
Cross Reference
Introduction
To understand associated biological information of Tauroursodeoxycholic acid, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Tauroursodeoxycholic acid?
Tauroursodeoxycholic acid is suspected in Endothelial dysfunction, Hyperglycemia, Obesity, neurogenic hypertension, Cholestatic liver disease, Heart failure and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
- Diabetes (3)
- Am. J. Physiol. Heart Circ. Physiol. (1)
- Am. J. Physiol. Lung Cell Mol. Physiol. (1)
- Others (5)
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Tauroursodeoxycholic acid
PubChem Associated disorders and diseases
What pathways are associated with Tauroursodeoxycholic acid
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Tauroursodeoxycholic acid?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Tauroursodeoxycholic acid?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Tauroursodeoxycholic acid?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with Tauroursodeoxycholic acid?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with Tauroursodeoxycholic acid?
Disease model
Disease model are used in the study 'Bile Acids Reduce Prion Conversion, Reduce Neuronal Loss, and Prolong Male Survival in Models of Prion Disease.' (Cortez LM et al., 2015).
Related references are published most in these journals:
| Model | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
NCBI Entrez Crosslinks
All references with Tauroursodeoxycholic acid
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Watanabe N and Lam E | BAX inhibitor-1 modulates endoplasmic reticulum stress-mediated programmed cell death in Arabidopsis. | 2008 | J. Biol. Chem. | pmid:18039663 |
| Xie Y et al. | Conditional intestinal lipotoxicity in Apobec-1-/- Mttp-IKO mice: a survival advantage for mammalian intestinal apolipoprotein B mRNA editing. | 2007 | J. Biol. Chem. | pmid:17855359 |
| de Almeida SF et al. | Chemical chaperones reduce endoplasmic reticulum stress and prevent mutant HFE aggregate formation. | 2007 | J. Biol. Chem. | pmid:17626021 |
| Sabeva NS et al. | Defects in the leptin axis reduce abundance of the ABCG5-ABCG8 sterol transporter in liver. | 2007 | J. Biol. Chem. | pmid:17561514 |
| Ved R et al. | Similar patterns of mitochondrial vulnerability and rescue induced by genetic modification of alpha-synuclein, parkin, and DJ-1 in Caenorhabditis elegans. | 2005 | J. Biol. Chem. | pmid:16239214 |
| Schmidt DR et al. | Regulation of bile acid synthesis by fat-soluble vitamins A and D. | 2010 | J. Biol. Chem. | pmid:20233723 |
| Beuers U et al. | Taurolithocholic acid exerts cholestatic effects via phosphatidylinositol 3-kinase-dependent mechanisms in perfused rat livers and rat hepatocyte couplets. | 2003 | J. Biol. Chem. | pmid:12626520 |
| Kirkpatrick CL et al. | Hepatic nuclear factor 1alpha (HNF1alpha) dysfunction down-regulates X-box-binding protein 1 (XBP1) and sensitizes beta-cells to endoplasmic reticulum stress. | 2011 | J. Biol. Chem. | pmid:21784843 |
| Amaral JD et al. | p53 is a key molecular target of ursodeoxycholic acid in regulating apoptosis. | 2007 | J. Biol. Chem. | pmid:17881359 |
| Hassan IH et al. | Influenza A viral replication is blocked by inhibition of the inositol-requiring enzyme 1 (IRE1) stress pathway. | 2012 | J. Biol. Chem. | pmid:22194594 |
| Hua Y et al. | Tauroursodeoxycholic acid attenuates lipid accumulation in endoplasmic reticulum-stressed macrophages. | 2010 | J. Cardiovasc. Pharmacol. | pmid:19834331 |
| Debattisti V et al. | Reduction of endoplasmic reticulum stress attenuates the defects caused by Drosophila mitofusin depletion. | 2014 | J. Cell Biol. | pmid:24469638 |
| Rodrigues CM et al. | Neuroprotection by a bile acid in an acute stroke model in the rat. | 2002 | J. Cereb. Blood Flow Metab. | pmid:11919517 |
| Tessier E et al. | High-performance liquid chromatographic mass spectrometric method for the determination of ursodeoxycholic acid and its glycine and taurine conjugates in human plasma. | 2003 | J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. | pmid:14643509 |
| Beuers U et al. | Tauroursodeoxycholic acid stimulates hepatocellular exocytosis and mobilizes extracellular Ca++ mechanisms defective in cholestasis. | 1993 | J. Clin. Invest. | pmid:8254052 |
| Young CN et al. | ER stress in the brain subfornical organ mediates angiotensin-dependent hypertension. | 2012 | J. Clin. Invest. | pmid:23064361 |
| Liu Y et al. | Hepatoprotection by the farnesoid X receptor agonist GW4064 in rat models of intra- and extrahepatic cholestasis. | 2003 | J. Clin. Invest. | pmid:14623915 |
| Yamaguchi Y et al. | Taurin-conjugated ursodeoxycholic acid has a reversible inhibitory effect on human keratinocyte growth. | 1998 | J. Dermatol. Sci. | pmid:9747660 |
| Marumo T et al. | Biliary excretion of bile acids and organic anions in rats with dichloroethylene-induced bile canalicular injury. | 2004 | J. Gastroenterol. | pmid:15549452 |
| Hamano M et al. | Lipid overloading during liver regeneration causes delayed hepatocyte DNA replication by increasing ER stress in mice with simple hepatic steatosis. | 2014 | J. Gastroenterol. | pmid:23512345 |
| Azer SA et al. | Hepatoprotection in ethinylestradiol-treated rats is provided by tauroursodeoxycholic acid, but not by ursodeoxycholic acid. | 1995 May-Jun | J. Gastroenterol. Hepatol. | pmid:7548801 |
| Funaoka M et al. | Tauroursodeoxycholic acid enhances phagocytosis of the cultured rat Kupffer cell. | 1999 | J. Gastroenterol. Hepatol. | pmid:10440209 |
| Takikawa H et al. | Absorption of unconjugated bile acids and tauroursodeoxycholate in the rat intestine. | 1997 | J. Gastroenterol. Hepatol. | pmid:9504891 |
| Sugata K et al. | Differential effects between tauroursodeoxycholic and taurochenodeoxycholic acids in hepatic fibrosis: an assessment by primary cultured Ito and Kupffer cells from the rat liver. | 1996 | J. Gastroenterol. Hepatol. | pmid:8743917 |
| Nonaka M et al. | Cytoprotective effect of tauroursodeoxycholate on hepatocyte apoptosis induced by peroxisome proliferator-activated receptor gamma ligand. | 2008 | J. Gastroenterol. Hepatol. | pmid:17868335 |
| Takikawa H et al. | Effect of tauro-alpha-muricholate and tauro-beta-muricholate on oestradiol-17 beta-glucuronide-induced cholestasis in rats. | 1997 | J. Gastroenterol. Hepatol. | pmid:9076630 |
| Tachizawa H et al. | Effects of colchicine on the maximum biliary excretion of cholephilic compounds in rats. | 2004 | J. Gastroenterol. Hepatol. | pmid:15304119 |
| Takayanagi M et al. | Biliary excretion of olmesartan, an anigotensin II receptor antagonist, in the rat. | 2005 | J. Gastroenterol. Hepatol. | pmid:15853995 |
| Chazouillères O et al. | Effect of bile acids on ischemia-reperfusion liver injury. | 1991 | J. Hepatol. | pmid:1808225 |
| Castro RE et al. | A distinct microarray gene expression profile in primary rat hepatocytes incubated with ursodeoxycholic acid. | 2005 | J. Hepatol. | pmid:15885361 |
| van Nieuwerk CM et al. | The role of bile salt composition in liver pathology of mdr2 (-/-) mice: differences between males and females. | 1997 | J. Hepatol. | pmid:9148004 |
| Baiocchi L et al. | Taurohyodeoxycholate- and tauroursodeoxycholate-induced hypercholeresis is augmented in bile duct ligated rats. | 2003 | J. Hepatol. | pmid:12547401 |
| Marteau C et al. | Effect of various bile salts on calcium concentration and calcium carbonate saturation of rat bile. | 1988 | J. Hepatol. | pmid:3183351 |
| Schölmerich J et al. | Tauroursodeoxycholate prevents taurolithocholate-induced cholestasis and toxicity in rat liver. | 1990 | J. Hepatol. | pmid:2365980 |
| Ono T et al. | Effect of tauroursodeoxycholic acid on bile flow and calcium excretion in ischemia-reperfusion injury of rat livers. | 1995 | J. Hepatol. | pmid:8583148 |
| Perez Barriocanal F et al. | Influence of backward perfusion on ursodeoxycholate-induced choleresis in isolated in situ rat liver. | 1990 | J. Hepatol. | pmid:2254627 |
| Benz C et al. | Effect of tauroursodeoxycholic acid on bile-acid-induced apoptosis and cytolysis in rat hepatocytes. | 1998 | J. Hepatol. | pmid:9537871 |
| Schoemaker MH et al. | Resistance of rat hepatocytes against bile acid-induced apoptosis in cholestatic liver injury is due to nuclear factor-kappa B activation. | 2003 | J. Hepatol. | pmid:12873810 |
| Sano N et al. | Estradiol-17 beta-glucuronide-induced cholestasis. Effects of ursodeoxycholate-3-O-glucuronide and 3,7-disulfate. | 1993 | J. Hepatol. | pmid:8445238 |
| Hohenester S et al. | Phosphatidylinositol-3-kinase p110γ contributes to bile salt-induced apoptosis in primary rat hepatocytes and human hepatoma cells. | 2010 | J. Hepatol. | pmid:20675006 |
| Pusl T et al. | Gap junctional intercellular communication is not needed for the anticholestatic effect of tauroursodeoxycholic acid in mouse liver. | 2005 | J. Hepatol. | pmid:15763348 |
| Milkiewicz P et al. | Effect of tauroursodeoxycholate and S-adenosyl-L-methionine on 17beta-estradiol glucuronide-induced cholestasis. | 2001 | J. Hepatol. | pmid:11281545 |
| Cai W et al. | Interferon-alpha-induced modulation of glucocorticoid and serotonin receptors as a mechanism of depression. | 2005 | J. Hepatol. | pmid:15885359 |
| Arrese M et al. | Adaptive regulation of hepatic bile salt transport: role of bile salt hydrophobicity and microtubule-dependent vesicular pathway. | 1997 | J. Hepatol. | pmid:9075679 |
| Vendemiale G et al. | Ethanol-induced changes of intracellular thiol compartmentation and protein redox status in the rat liver: effect of tauroursodeoxycholate. | 1998 | J. Hepatol. | pmid:9537863 |
| Moschetta A et al. | Hydrophilic bile salts enhance differential distribution of sphingomyelin and phosphatidylcholine between micellar and vesicular phases: potential implications for their effects in vivo. | 2001 | J. Hepatol. | pmid:11394647 |
| Takikawa H et al. | Colchicine inhibits lithocholate-3-O-glucuronide-induced cholestasis in rats. | 1995 | J. Hepatol. | pmid:7751593 |
| Pan XL et al. | Efficacy and safety of tauroursodeoxycholic acid in the treatment of liver cirrhosis: a double-blind randomized controlled trial. | 2013 | J. Huazhong Univ. Sci. Technol. Med. Sci. | pmid:23592128 |
| Min JH et al. | Oral solubilized ursodeoxycholic acid therapy in amyotrophic lateral sclerosis: a randomized cross-over trial. | 2012 | J. Korean Med. Sci. | pmid:22323869 |
| Rao YP et al. | Activation of protein kinase C alpha and delta by bile acids: correlation with bile acid structure and diacylglycerol formation. | 1997 | J. Lipid Res. | pmid:9458268 |